COMPARISON OF HOSPITAL COSTS VS OUTPATIENT OF APPLICATION OF INTRAVENOUS INJECTABLE THERAPY IN THE TREATMENT OF PERIPHERAL OCLUSIVE ARTERIAL DISEASE IN COLOMBIA
Author(s)
Tamayo C1, Upegui A2, Robles A2, Puentes SY3
1U Nacional, Bogota, Colombia, 2Universidad Externado, Bogota, Colombia, 3ECCI, Bogota, Colombia
OBJECTIVES: To develop a costing exercise that allows comparing the hospital vs ambulatory costs of application of intravenous injectable vasodilator therapy in the treatment of Peripheral Occlusive Artery Disease (POAD) in Colombia. METHODS: The increase in ambulatory or domiciliary medical care is in effect a systemic response to the increased needs of the Colombian health system, specifically the cost of beds occupancy and hospital rooms, which in some cases are not necessary. Through the collection of clinical data on the management of the application of a vasodilator pharmacological therapy for patients with POAD in the Fontaine III and IV stages, an exercise of economic cost was developed that allows comparing the options of intrahospital vs ambulatory application, in cases where this procedure can be performed ambulatorily according to medical criteria. The costs of resources and inputs were taken from the SOAT 2001 + 30% tariff manual and were adjusted when quartiles 25, 50 and 75 were required to ensure that the extreme values found in the database were not to affect the average estimation. RESULTS: The results are presented as the sum of the expenditure in the application and use of inputs and resources, such as single room of average complexity, macro drip equipment, intrahospital care by general medicine, among others. The option of application for ambulatory or domiciliary management represents a saving of about 28.14% to the Colombian health system in this specific therapy for POAD. CONCLUSIONS: The results of the exercise suggest the existence of thrifty alternatives of management options for the application of medications in an outpatient or domiciliary way without having to carry costs to the health system directly with the occupation of spaces in hospitals that can be used in a more efficient way.
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PHS40
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Cardiovascular Disorders